ResearchSafe

LSZ – LSD‑Analog That Might Be Too Good to Be True?

Posted by greg208 in Research & News - 7 points, 3 comments.

I came across a paper on LSZ published in the Journal of Pharmacology last week (link: /peptides/lsz) that claims it gives Alc-like visuals but with a shorter 3–4 hr window. They say it could be useful for receptor‑mapping and even neuroprotection. Not gonna lie, the idea sounds exciting – a rigid LSD analogue that could lock the shape into a single conformation and produce less body load than full LSD.

But the paper is purely preclinical and the only data are in vitro and a single mouse study. For me, the real test is how it feels in humans, and we've had no human trials yet. I’ve done LSD before, and the visual hallucinations can be intense; a shorter duration could reduce the risk of prolonged anxiety but the paper doesn’t address safety in people.

It feels like hype until we see real human data. Does anyone else think we should wait for clinical safety studies before buying into LSZ’s promise, or is it worth trying in a controlled setting?

Comments

  • kayla_s: I’d be cautious. I’ve tried LSD a few times, and the intense visuals can stay with you even after the trip, so a shorter window sounds tempting, but the safety profile worries me. In a single mouse study that’s a huge leap to human dosing, especially with a rigid analogue that could lock into a specific shape. I’d prefer to see human safety data or pharmacokinetics before even considering it in a controlled setting. Have anyone heard of any early-phase trials or reports from users who’ve tried
  • greg208: Thanks for the thoughts. I agree the rigid shape could change receptor binding and might give a cleaner profile, but with the 3‑4 hr window I’m still wary if that’s enough to avoid lingering visual carry‑over you mentioned. I’ve seen no early‑phase data or user reports so far, just that single mouse study. Do you know if anyone’s doing PK in rats or looking at human dose‑range estimations?
  • greg208: I feel you, not gonna lie. From what I can see, LSZ is still a long way from human data. Even a short mouse study doesn't give a clear safety picture, especially with a rigid shape that could lock into place. I'd hate to see people jump in without PK or early phase dataön. Anything else you’ve heard?

Community discussion - research and educational context only. Not medical advice.